PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+14.25%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$3.56B
AUM Growth
+$3.56B
(+18%)
Cap. Flow
+$344M
Cap. Flow
% of AUM
9.68%
Top 10 Holdings %
Top 10 Hldgs %
49.76%
Holding
165
New
31
Increased
30
Reduced
29
Closed
32
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$97.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$64.9M |
| 3 |
Ascendis Pharma
ASND
|
$64.3M |
| 4 |
VYNE Therapeutics
VYNE
|
$60.1M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$34.2M |
Top Sells
| 1 |
AnaptysBio
ANAB
|
$54M |
| 2 |
Neurocrine Biosciences
NBIX
|
$32.3M |
| 3 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$25.2M |
| 4 |
Intuitive Surgical
ISRG
|
$25M |
| 5 |
Zimmer Biomet
ZBH
|
$24.1M |
Sector Composition
| 1 | Healthcare | 96.13% |
| 2 | Consumer Discretionary | 0.06% |
| 3 | Industrials | 0.02% |
| 4 | Technology | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Neurocrine Biosciences
NBIX
$13.8B
| $395M | 11.06% | 4,761,989 -389,600 | -8% | -$32.3M |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $301M | 8.44% | 20,024,424 +2,135,827 | +12% | +$32.1M |
|
|
GBT
3
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $241M | 6.75% | 4,989,066 +100,000 | +2% | +$4.83M |
|
|
ZGNX
4
DELISTED
Zogenix, Inc.
ZGNX
| $159M | 4.45% | 3,970,357 | – | – |
|
5
Alnylam Pharmaceuticals
ALNY
$58.5B
| $153M | 4.27% | 1,280,802 -50,000 | -4% | -$5.95M |
|
|
LJPC
6
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $128M | 3.6% | 4,313,611 +925,000 | +27% | +$27.5M |
|
7
Iovance Biotherapeutics
IOVA
$807M
| $104M | 2.92% | 6,162,202 +1,386,088 | +29% | +$23.4M |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $97.4M | 2.73% | +873,450 | New | +$97.4M |
|
|
ABMD
9
DELISTED
Abiomed Inc
ABMD
| $96.7M | 2.71% | 332,449 +117,449 | +55% | +$34.2M |
|
|
BPMC
10
DELISTED
Blueprint Medicines
BPMC
| $94.5M | 2.65% | 1,030,434 -110,000 | -10% | -$10.1M |
|
|
DOVA
11
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $75.4M | 2.11% | 2,780,977 +971,962 | +54% | +$26.4M |
|
|
CORI
12
DELISTED
Corium International, Inc.
CORI
| $72.9M | 2.04% | 6,357,133 +510,000 | +9% | +$5.85M |
|
13
Travere Therapeutics
TVTX
$1.56B
| $71.8M | 2.01% | 3,212,871 +540,346 | +20% | +$12.1M |
|
|
BHVN
14
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $71.2M | 1.99% | 2,927,449 +2,666,315 | +1,021% | +$64.9M |
|
|
15
Ascendis Pharma
ASND
$11.8B
| $64.3M | 1.8% | +982,647 | New | +$64.3M |
|
16
CytomX Therapeutics
CTMX
$336M
| $62.8M | 1.76% | 2,208,812 -281,569 | -11% | -$8.01M |
|
|
17
VYNE Therapeutics
VYNE
$8.16M
| $60.1M | 1.68% | +1,598,958 | New | +$60.1M |
|
|
XLRN
18
DELISTED
Acceleron Pharma Inc.
XLRN
| $59.3M | 1.66% | 1,516,259 -100,000 | -6% | -$3.91M |
|
|
ALBO
19
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $55.5M | 1.55% | 1,704,330 +384,330 | +29% | +$12.5M |
|
|
DBVT
20
DBV Technologies
DBVT
$264M
| $48.3M | 1.35% | 2,093,498 +1,114,879 | +114% | +$25.7M |
|
21
Merit Medical Systems
MMSI
$5.36B
| $47.4M | 1.33% | 1,045,013 +171,000 | +20% | +$7.75M |
|
22
argenx
ARGX
$43.6B
| $43.2M | 1.21% | 537,361 | – | – |
|
|
MYOK
23
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $40.7M | 1.14% | 834,679 +123,953 | +17% | +$6.05M |
|
24
Xencor
XNCR
$580M
| $39.5M | 1.11% | 1,318,095 +5,000 | +0.4% | +$150K |
|
|
AVXS
25
DELISTED
AveXis, Inc. Common Stock
AVXS
| $34.2M | 0.96% | 276,400 -203,741 | -42% | -$25.2M |
|